University of California San Francisco
Give to UCSF
The campus community is invited to the next Chancellor’s Health Policy Lecture on Feb. 24 featuring Sidney Wolfe, an outspoken critic of the FDA and pharmaceutical industry.
Current guidelines for when to prescribe popular cholesterol-lowering drugs called statins would produce cost-effective results and would save thousands of lives every year if they were followed more closely by physicians and patients, according to a new study led by researchers at the University of California, San Francisco.
Weekly visits by the San Francisco nonprofit group BayKids offer young UCSF patients the chance to write, direct and star in their own short films.
Different cell types in the brain are vulnerable in different degenerative brain diseases – Alzheimer’s, Parkinson’s and multiple sclerosis, for instance.
A 3-year-old Iraqi boy who underwent surgery at UCSF Medical Center last month to restore his hearing will have his hearing tested on February 17.
To treat neurodegenerative diseases such as Alzheimer’s, UCSF researchers have developed a new strategy for delivering gene therapy to the brain cells that stand to benefit most.
New and emerging biomedical approaches to HIV/AIDS prevention will be the focus of a daylong symposium on February 24 sponsored by the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research (CFAR) and the UCSF Center for AIDS Prevention Studies.
The new Center for Translational and Policy Research on Personalized Medicine will examine the potential benefits and pitfalls as medical care moves beyond the one-size-fits-all approach.
Lawrence Pitts, 68, a longtime UC faculty member, past chair of the UC Academic Senate and professor of neurosurgery at UCSF, was named as interim provost and executive vice president for academic affairs of the UC system.
Years after being told she had six months to live, metastatic cancer patient Lori Nichols says she feels “wonderful,” thanks in part to a treatment regimen that combines traditional therapies with cutting-edge innovations.
Rita Redberg, a cardiologist at UCSF Medical Center and a longtime leader in the field of women’s cardiovascular health, has added the role of “prestigious journal editor” to her already impressive résumé.
Cancer doctors may be writing the prescriptions for new generations of drugs, but some financially hard-pressed patients are not having those prescriptions filled.
New UCSF Faculty, February 2009
New UCSF Faculty, February 2009
UCSF is preparing for a site visit next week by a panel of experts who will review the University as part of an accreditation process by the Western Association of Schools and Colleges (WASC).
A new drug that blocks cancer's main source of growth has been created in the lab and proven effective in mice, scientists are reporting. It is now being readied for clinical trials in patients.
A man was convicted on Tuesday for making threatening phone calls to several UCSF researchers who conduct studies with animals.
UCSF students recently shared their love and knowledge of pharmaceutical sciences with the next generation during Science Day at the Mission Bay campus
The UCSF School of Dentistry will offer free cleanings, dental sealants and fluoride treatments as part of the citywide “Give Kids a Smile Day.”
Over the past three years, the QB3 Garage at UCSF Mission Bay has seen five biotech start-ups emerge from obscurity into the marketplace, and several more are well on their way.
Mitchell Feldman, professor of medicine, has been appointed as co-editor of the official peer-reviewed scientific publication of the Society of General Internal Medicine.
Lung cancer research at UCSF is poised to leap forward, thanks to a big bank. No, not some teetering financial institution down the street. What UCSF has is an invaluable tissue bank.
A UCSF postdoctoral scholar is singled out for his work exploring how natural killer cells adapt to ward off infection and cancer more effectively.
In recent years, there has been an increasing number of drugs pulled from the market, and many observers have been blaming the drug approval process of an understaffed, underfunded, industry-dependent US Food and Drug Administration (FDA). But even old drugs, predating today’s FDA environment, also are subject to recall.